Skip to search formSkip to main contentSkip to account menu

Suksilep

Known as: Jenapharm Brand of Ethosuximide, Suxilep, Wernigerode Brand of Ethosuximide 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ethosuximide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Die Burgensammlung des GNM – Zeichnungen von Graf Stolberg-Wernigerode
BLICKPUNKT MAI . Zur Vorbereitung der ausstellung „mythos Burg“, die vom 8. Juli bis zum 7. november 2010 im germanischen… 
2006
2006
[Epilepsy with electrical status epilepticus during slow sleep: diagnostic criteria and approaches to therapy].
Fourteen patients, aged from 5 to 14 years, with syndrome of electrical status epilepticus during slow sleep (ESESS) have been… 
1984
1984
Effect of hydrocortisone and desoxycorticosterone on some reductases, esterases and synthetases.
Corticosteroids, applied in single high doses, are known to inhibit the activity of mixed function oxidases. Experiments on male… 
1984
1984
Comparative study of the anticonvulsive activity of N-aminomethylpiperazine-3,3-diethyl 2,4-pyridinedione with the activity of known antiepileptic agents.
N-aminomethylpiperazine-3,3-diethyl-2,4-pyridinedione (DKMP) is a newly synthesized compound with a marked anticonvulsive effect… 
1983
1983
[Prognosis in primarily pure absence epilepsy].
17 patients out of a total of 93 treated for primarily pure absence-epilepsy experienced secondary grand mal-seizures and eeg of… 
1977
1977
[Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
1975
1975
[Mutagenic activity of psychotropic drugs].
Mutagenic activity of 33 psychotropic drugs was studied in Drosophila metanogaster according to the CLB method. The drugs are the… 
1971
1971
[Results of Suxilep therapy in epileptic seizures in childhood].
1969
1969
[Experiences with suxilep in childhood epilepsy].